KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Change in Accured Expenses (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Change in Accured Expenses for 6 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 120.97% year-over-year to $3.6 million, compared with a TTM value of $1.6 million through Dec 2025, up 162.86%, and an annual FY2025 reading of $1.6 million, up 162.86% over the prior year.
  • Change in Accured Expenses was $3.6 million for Q4 2025 at Clover Health Investments, up from -$8.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $15.0 million in Q1 2023 and bottomed at -$19.3 million in Q2 2023.
  • Average Change in Accured Expenses over 5 years is $780000.0, with a median of $3.1 million recorded in 2022.
  • The sharpest move saw Change in Accured Expenses surged 2436.53% in 2021, then tumbled 721.96% in 2023.
  • Year by year, Change in Accured Expenses stood at $3.9 million in 2021, then tumbled by 150.27% to -$2.0 million in 2022, then surged by 463.37% to $7.2 million in 2023, then tumbled by 337.49% to -$17.0 million in 2024, then surged by 120.97% to $3.6 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CLOV at $3.6 million in Q4 2025, -$8.0 million in Q3 2025, and $10.1 million in Q2 2025.